Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SCN1A mutations and epilepsy.

John C Mulley1, Ingrid E Scheffer, Steven Petrou

  • 1Department of Genetic Medicine, Women's and Children's Hospital, North Adelaide, South Australia, Australia.

Human Mutation
|May 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Utility of Genome-wide DNA Methylation Analysis in Genetically Unsolved Developmental and Epileptic Encephalopathies and Refinement of a CHD2 Episignature.

medRxiv : the preprint server for health sciences·2023
Same author

Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies.

Neurology·2023
Same author

Aicardi Syndrome Is a Genetically Heterogeneous Disorder.

Genes·2023
Same author

Familial Mesial Temporal Lobe Epilepsy: Clinical Spectrum and Genetic Evidence for a Polygenic Architecture.

Annals of neurology·2023
Same author

Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study.

The Lancet. Neurology·2023
Same author

Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial.

Epilepsia·2023
Same journal

RETRACTION: "Differential Effects of AKT1(p.E17K) Expression on Human Mammary Luminal Epithelial and Myoepithelial Cells".

Human mutation·2026
Same journal

Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort.

Human mutation·2026
Same journal

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026
Same journal

Modeling the Effects of Single Nucleotide Polymorphisms (SNPs) on the Structure and Function of the Human <i>RET</i> Gene: An In Silico Study.

Human mutation·2026
Same journal

Driver Mutation Subtypes Differentially Shape Immune Evasion Landscapes in Melanoma: An AI-Driven Inflammatory Pathway Model Implicating CCNE1.

Human mutation·2026
Same journal

Comment on "When the Outcome Contains the Exposure: Methodological Limits of a Genome-Wide Cross-Trait Analysis of Type 2 Diabetes and MASLD".

Human mutation·2026
See all related articles

Genetic defects in the SCN1A gene cause severe childhood epilepsy and GEFS+. This study collates over 100 novel SCN1A mutations, highlighting its clinical relevance in epilepsy.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • SCN1A gene encodes alpha pore-forming subunits of sodium channels.
  • Mutations in SCN1A are linked to generalized epilepsy with febrile seizures plus (GEFS+) and severe childhood epileptic encephalopathies like SMEI.
  • The SCN1A gene is located on chromosome 2q24 and comprises 26 exons.

Purpose of the Study:

  • To collate all published mutations in the SCN1A gene.
  • To identify and characterize novel SCN1A mutations.
  • To analyze the distribution and clinical relevance of SCN1A mutations in epilepsy.

Main Methods:

  • Literature review and collation of published SCN1A mutations.
  • Identification and characterization of novel SCN1A mutations.

Related Experiment Videos

  • Analysis of mutation distribution within the SCN1A gene.
  • Review of functional studies correlating SCN1A mutations with channel properties and clinical phenotypes.

    • Main Results:

    • Over 100 novel SCN1A mutations have been identified, spread throughout the gene.
    • A clustering of mutations is observed in the C-terminus and specific loops of the SCN1A protein.
    • Debilitating mutations are often de novo.
    • Functional studies show no consistent genotype-phenotype correlation.

    Conclusions:

    • SCN1A is the most clinically relevant epilepsy gene identified to date, with the largest number of characterized mutations.
    • The findings underscore the significant role of SCN1A in the pathogenesis of various epilepsy syndromes.
    • Further research is needed to understand the functional consequences of SCN1A mutations and their relationship to clinical presentation.